Role of HPV DNA testing in modern gynaecological practice

Guglielmo Ronco, Paolo Giorgi Rossi

Research output: Contribution to journalReview articlepeer-review


The identification of some types of human papillomavirus (HPV) as necessary, but not sufficient, cause of cervical cancer has suggested the use of HPV testing in cervical cancer prevention. A large number of studies has provided evidence supporting its application (1) as primary screening test, (2) for triaging borderline cytology, (3) for follow-up after positive primary test but no abnormal histology and (4) as a test of cure. They also allowed a reasonably good definition of the appropriate policies and protocols, leading to the delivery of evidence-based guidelines resulting from a systematic review of the literature. In this chapter, we present a critical analysis of the recommendations of the main European and North American guidelines relative to industrialised countries.

Original languageEnglish
Pages (from-to)107-118
Number of pages12
JournalBest Practice and Research: Clinical Obstetrics and Gynaecology
Publication statusPublished - Feb 1 2018


  • Cervical cancer
  • Follow-up
  • Human papillomavirus
  • Primary test
  • Screening
  • Test of cure

ASJC Scopus subject areas

  • Obstetrics and Gynaecology


Dive into the research topics of 'Role of HPV DNA testing in modern gynaecological practice'. Together they form a unique fingerprint.

Cite this